ScholarIQanswers from OpenAlex & ORCID
Brian D. Kavanagh
ResearcherPublications, citations & collaboration network
Brian D. Kavanagh is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Brian D. Kavanagh have?
ScholarIQindexed works
Brian D. Kavanagh has 478 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Brian D. Kavanagh have?
ScholarIQcitation count
Brian D. Kavanagh has 23,897 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Brian D. Kavanagh?
ScholarIQh-index
Brian D. Kavanagh has an h-index of 67 in OpenAlex.
What is the i10-index of Brian D. Kavanagh?
ScholarIQi10-index
Brian D. Kavanagh has an i10-index of 202 in OpenAlex.
What is the ORCID of Brian D. Kavanagh?
ScholarIQorcid
The ORCID for Brian D. Kavanagh is on the source record.
What is the OpenAlex record for Brian D. Kavanagh?
ScholarIQopenalex
The OpenAlex for Brian D. Kavanagh is on the source record.
What are the most-cited papers on Brian D. Kavanagh?
ScholarIQmost cited works
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez, Chad Tang, Jianjun Zhang, George R. Blumenschein, Mike Hernández, J. Jack Lee, Rong Ye, David A. Palma, Alexander V. Louie, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, James W. Welsh, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Anne S. Tsao, Boris Sepesi, Stephen G. Swisher, John V. Heymach
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez, George R. Blumenschein, J Jack Lee, Mike Hernández, Rong Ye, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, Boris Sepesi, William N. William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G. Swisher, John V. Heymach
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
William J. Magnuson, N.H. Lester-Coll, Abraham J. Wu, Jonathan T. Yang, Natalie A. Lockney, Naamit K. Gerber, Kathryn Beal, Arya Amini, Tejas Patil, Brian D. Kavanagh, D. Ross Camidge, S.E. Braunstein, Lauren Boreta, Suresh Kumar Balasubramanian, Manmeet S. Ahluwalia, Niteshkumar G. Rana, Albert Attia, Scott Gettinger, Joseph N. Contessa, James B. Yu, Veronica Chiang
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
Chad G. Rusthoven, Masaaki Yamamoto, Denise Bernhardt, Derek Smith, Dexiang Gao, Toru Serizawa, Shoji Yomo, Hitoshi Aiyama, Yoshinori Higuchi, Takashi Shuto, Atsuya Akabane, Yasunori Sato, Ajay Niranjan, Andrew Faramand, L. Dade Lunsford, James McInerney, Leonard Tuanquin, Brad E. Zacharia, Veronica Chiang, Charu Singh, James B. Yu, Steve Braunstein, David Mathieu, Charles Touchette, Cheng‐Chia Lee, Huai‐Che Yang, Ayal A. Aizer, Daniel Cagney, Michael D. Chan, Douglas Kondziolka, Kenneth Bernstein, Joshua S. Silverman, Inga S. Grills, Z.A. Siddiqui, Justin C. Yuan, Jason P. Sheehan, Diogo Cordeiro, Kename Nosaki, T. Seto, Christopher P. Deibert, Vivek Verma, Samuel E. Day, Lia M. Halasz, Ronald E. Warnick, Daniel M. Trifiletti, Joshua D. Palmer, Albert Attia, Benjamin Li, Christopher P. Cifarelli, Paul D. Brown, John A. Vargo, Stephanie E. Combs, Kerstin A. Kessel, Stefan Rieken, Samir Patel, Matthias Gückenberger, Nicolaus Andratschke, Brian D. Kavanagh, Tyler P. Robin